David has worked in community based mental health services in the UK for over thirty years developing services for people with complex care needs and enduring mental health problems in a career spanning the voluntary sector, local authority services, and the NHS.. From 2009 - 2011 he was the Dementia Implementation Lead for Commissioning Support for London, working with commissioners across London to improve dementia services. He is an independent writer and researcher on dementia support and services for Black and minority ethnic communities, working with a number of projects and initiatives.

Dementia, Mental Health

Dr. Majaz Moonis is a neurologist in Worcester, Massachusetts and is affiliated with multiple hospitals in the area, including Health Alliance Hospital and UMass Memorial Medical Center. He received his medical degree from Delhi University College of Medical Sciences and has been in practice for more than 20 years. Dr. Moonis accepts several types of health insurance, listed below. He is one of 24 doctors at Health Alliance Hospital and one of 81 at UMass Memorial Medical Center who specialize in Neurology.

My research focuses on several interrelated areas that affect stroke and dementia outcomes. More specifically I am interested in the following areas: Outcome research related to specific interventions affecting the vascular endothelium in stroke and Alzheimer’s disease; health care disparities relating to race, age and gender in stroke and dementia; optimal management and effects on primary and secondary stroke prevention; genetic markers in cryptogenic stroke to aid in sub-classification and management; clinical trials in acute stroke and stroke prevention; data mining in sleep related disorders; and stroke.

Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration

The major focus of this laboratory has been to study the mechanisms of topographic regulation of neuronal cytoskeletal proteins regulation by phosphorylation and neurodegeneration.

Dr Girouard completed her PhD in cardiovascular physiology in 2002 at the Université de Montreal under the supervision of Dr J. de Champlain, a specialist in the field of hypertension. She then pursued with two fellowships both on the study of cerebrovascular regulation: one at the Weill Medical College of Cornell University and a second one at the University of Vermont under the supervisions of Dr. Costantino Iadecola and Dr Mark T. Nelson, respectively. She is now associate professor at the Department of pharmacology and physiology at the Université de Montréal and the director of the laboratory of neurovascular pharmacology since 2008. Along her career, Dr Girouard received prices including the Merck New investigator price of the ‘Société Québécoise d’Hypertension Artérielle’ and the Young Investigator Award from the Heart and Stroke Foundation of Canada. She recently was nominated Fellow of the American Heart Association. She is involved in many Societies related to Hypertension and neurosciences in particular the ‘Société Québécoise d’Hypertension Artérielle’ and the ‘International Society of Cerebral Blood Flow and Metabolism’ in which she is member of the Board of Directors.

The research interests of Dr Girouard are the study of the mechanisms underlying cerebrovascular regulation in health and diseases especialy in the context of hypertension and arterial stiffness. The main objective of her research is to find therapeutical targets to protect the brain from vascular diseases. To reach this objective, she is using various techniques from molecular biology to brain imaging in mice and humans. She published mostly in the field of hypertension and cerebrovascular regulation.

Panteleimon Giannakopoulos has completed his MD at age of 23 years from the University of Athens and is board certified psychiatrist and psychotherapist from 1999. He completed his postgraduate training in London and Paris before taking the chair of old age psychiatry in Geneva. He has also a full training in cognitive neurosciences focusing on dementing conditions. He was the chairman of the Department of Psychiatry in Geneva from 2005 to 2015 before being appointed as medical director of the Forensic Psychiatry for the Geneva county. He has published more than 220 peer-reviewed articles (h index: 42), and has been serving as an editorial board member and reviwer of repute.

Identification of markers of cognitive decline in mild cognitive impairment, late-onset depression and bipolar disorders, Cognitive impact of vascular lesions in brain aging, Alzheimer’s disease (AD), Use of recombinant clusterin to prevent ischemic damage in organotypic cultures and after middle cerebral artery occlusion

Dr Meguro was educated at the Tohuku University at both undergraduate and post-graduate level. He obtained his PhD in Neurology and Geriatric Medicine. He has vast work experiences at the Centre-CYCERON-INSERM, in France and the ADRC, Washington University in St. Louis, School of Medicine. From 2005 till present, he is a Professor at the Department of Geriatric Behavioral Neurology, Tohoku University Graduate School of Medicine. He is board-certified by the Japanese Academic Societies in the specialty of Internal Medicine, Clinical Neurology, Stroke Medicine, Geriatric Psychiatry, Dementia Medicine. He sat on the editorial Board of prestigious journal such as the Alzheimer Disease Associated Disorders, Dementia & Neuropsychology and the International Journal of Alzheimer’s Disease

Dementia, Alzheimer's disease related disorders, Neuropsychology

Dr.Jera KRUJA is a Member of Scientific Committee at European Academy of Neurology and Professor of Neurology at Mother Theresa University Hospital Center. Since 2014 she is (European representative) at Teaching Course Committee, World Federation of Neurology. During 2013-2014 she is a Rector of University of Medicine, Tirana and Member of editing board of OA Publishing London, WebMed Central Brain Editor, Albanian Medical Journal, Bulletin of Medical Sciences, University of Medicine, Tirana. She worked at Health National Contact Point, European Commission, CORDIS Fp7 programme(2010-2013). From 2003, she is a reviewer of European Journal of Neurology, Clinical Epidemiology, Neuropsychiatric Disease and Treatment, Journal of Epidemiology and Community Health, Journal of Pediatric Epilepsy. She is a Trainer of European Academy of Epilepsy since February 2003. She is the President of Albanian Society of Neurology (ASN) during 1998-2007.

Neurology, Neuroradiology, Epidemiology

Dr Priya Sharda spent her formative years building her career in one of the largest bed occupancy hospital, Hospital Kuala Lumpur, Malaysia. After coming out as a Neurosurgeon from University Sains Malaysia (USM), she spent another year there before embarking into another era in the Northern region of Malaysia’s’ primary tertiary Hospital for Neurosurgery, Penang General Hospital. She has published a few papers in reputed journals along her way despite busy schedule. She is also a keen trainer and spends time teaching post basic nursing as well as medical students.

Pediatric Neurosurgery Stroke Surgery Traumatic Brain Injury Pediatric Neurosurgical Anomalies.Stroke

Dr. Mohammad Mohsin Ali Farazi was born in 13th march 1969 in Bagerhat district, BANGLADESH. He obtained his MBBS from Sher-E-Bangla Medical College, Barisal, BANGLADESH in January 1995. After completion of internship training he joined in Government service in 1997. He served many government hospitals with efficiency and dignity. He completed his post graduation MS (Masters of Neurosurgery) from Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka , BANGLADESH in July 2008. After that he posted as Junior consultant (Neurosurgery) in Shaheed Sheikh Abu Naser Specialized Hospital, Khulna, BANGLADESH. Now he is working as Assistant Professor (Neurosurgery) in the same hospital. He did many Neurosurgical procedures both emergency and routine. He attended in many national and International conferences in home and abroad. He presented scientific papers in many seminars and symposiums. His scientific papers published in many national and international journals. He is the life member of Bangladesh Medical Association (BMA), Society of Surgeons of Bangladesh (SOSB), Bangladesh Society of Neurosurgeons (BSNS) and NeuroSpine Society of Bangladesh (NSSB).

Spinal Neurosurgery

WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong

His main research areas are Neuropsychiatry in Stroke, Substance abuse, Postnatal depression, dementia, cognitive impairment, depression, anxiety, apathy, fatigue, emotional incontinence, suicidality, insomnia, pain, and quality of life. Other research areas include psychiatric morbidity in Pneumoconiosis and Parkinson’s disease, Electroconvulsive Therapy, Schizophrenia and Psychogeriatrics

Mohammad Nazrul Hossain, passed MBBS from Sir Salimullah Medical College, Dhaka, Bangladesh in 2000. He got his fellowship in Neurosurgery from Bangladesh College of Physician and Surgeons (BCPS) in 2012.He was the first fellow in his subject from BCPS.His study was acknowledged by the BCPS and published in their journal. After successful completion of his fellowship he joined and worked in a world renowned chain hospital “APOLLO”, Dhaka, Bangladesh as neurosurgeon. During his neurosurgical carrier he worked with famous neurosurgeons of both national and international level. He joined “Jalalabad Ragib-Rabeya Medical College and Hospital” from Apollo in 2013 and established a fully new Neurosurgery department and serving the people of this area with their satisfaction.

Neurosurgery,

I was born in 1964, received my medical degree from the Faculty of Medicine at the University of Belgrade in 1989. In 1994, I became a neurologist. Over the course of my career, I took part in many additional courses, most notably: - a 6 month course in electroencephalography at the Institute of Neurology(1991) - a pediatric and neonatal EEG course at the University Hospital for pediatrics (1996) - ultrasonography of main head and neck blood vessels and transcranial doppler training (2000) In regards to my work experience, I have worked from 1989 until 2002 at the General Hospital in Pozarevac. In 2002, I moved to the Hospital for cerebrovascular diseases “Sveti Sava” in Belgrade, and have been there since. Today, my work mainly revolves around the latest treatments of blood vessel thrombosis, thrombolysis and thrombectomy. Since 2008, I have published numerous research papers both domestically and internationally. In 2014 I obtained the title of a primarius, the highest domestic distinction for a clinical physician.

treatments of blood vessel thrombosis, thrombolysis and thrombectomy

Marina Zueva, Professor of Pathophysiology, graduated from the Lomonosov Moscow State University (Physiology of Higher Nervous Activity), received her Ph.D. and Biol. Sci. D. from Moscow Helmholtz Research Institute of Eye Diseases. Currently, she is the Head of the Division of Clinical Physiology of Vision at the Moscow Helmholtz Research Institute of Eye Diseases. She has published over fifteen peer-reviewed full-length papers in English (over 100 in Russian) and presented near 70 topics at international conferences. Research Topics: Clinical physiology and electrophysiology of vision, neurophysiology; age-related and neurodegenerative disorders of the visual system and the brain, neurocognitive technologies of the restoration, maintenance and improvement of the brain activity and cognitive functions.

neurophysiology and neurodegenerative disorders of the visual system and the brain

Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration

The major focus of this laboratory has been to study the mechanisms of topographic regulation of neuronal cytoskeletal proteins regulation by phosphorylation and neurodegeneration.

Si Ching Lim has a special interest in dementia care particularly in patients with behavioural and psychological symptoms of dementia. She is currently In-charge of a 20 bedded dementia ward in a teaching hospital in Singapore and is responsible in developing the ward and training the staff in managing elderly with delirium and dementia with challenging behaviour. She is also an Adjunct Assistant Professor at National University of Singapore and Dukes Graduate Medical School.

Dementia

David has worked in community based mental health services in the UK for over thirty years developing services for people with complex care needs and enduring mental health problems in a career spanning the voluntary sector, local authority services, and the NHS.. From 2009 - 2011 he was the Dementia Implementation Lead for Commissioning Support for London, working with commissioners across London to improve dementia services. He is an independent writer and researcher on dementia support and services for Black and minority ethnic communities, working with a number of projects and initiatives.

Dementia, Mental Health

Dr. Gjumrakch Aliev, MD, PhD, President “GALLY” International Biomedical Research Institute Inc., San Antonio, Texas, USA. He also hold appointment with the University of Atlanta, Atlanta, Georgia, USA as a Professor of Cardiovascular, Neuropathology, Gerontology, Health Science and Healthcare Administration, and as a Leading Scientist , Institute of Physiologically Active Compounds. Russian Academy of Sciences, Moscow Region, Chernogolovka, Russian Federation. He received his MD in 1982, from the Baku Medical University (former USSR) with cum laude. Then he accomplished his PhD in Cardiovascular Diseases from the prestigious Russian Academy of the Medical Sciences, Moscow, Russia in 1988 with cum laude. He received postdoctoral training with Professor G. Burnstock in the University College of the London. He authored and coauthored more than 500 publications in the fields of neurodegenerative diseases research (Alzheimer disease), as well as cardio- and cerebrovascular disease, cancer, and electron microscopy. He is an outstanding teacher, scholar, and a renowned scientist in the area of cellular molecular physiology, and cardiovascular, and neurodegeneration-mediated pathologies including Alzheimer disease (AD). He is nationally and internationally reputed in his area. Dr. Aliev’s accomplishments in the area of biochemistry and cellular biology have tremendous implications for drug design towards CNS Neurological Disorders, AD, cancer, and cerebrovascular and neurodegeneration related pathologies. He is world-renowned expert in electron microscopy. His work has been published in numerous prestigious journals such as New England journal of Medicine, Nature Clinical Cardiology, J. Neuroscience, Scientific Reports, Circulation Research, Blood, J. Cellular and Molecular Medicine, Atherosclerosis, CNS Neurological Disorders & Drug Targets, international J. Biochemistry and Cell Biology and many others which reflect his leading role in his research areas. He is currently the Editor in Chiefs for “Central Nervous System Agents in Medicinal Chemistry”, “Applied Cell Biology”, “World Journal of Neuroscience”, “Open Journal of Psychiatry”, “Journal of Aging Science”, “Cardiovascular & Hematological Agents in Medicinal Chemistry”, “Immunology, Endocrine and Metabolic Agent in Medicinal Chemistry” as well as which by itself shows the voluminous and outstanding work he has accomplished in the area of cellular and molecular biology as well as aged associated clinical sciences. He is one of most cited authors in his fields with high impact factors.

dEMENTIA, Parkinson's disease, strokes and other brain diseases,

Dr. Foundas completed her undergraduate studies at Wellesley College, and went on to graduate from Louisiana State University School of Medicine in New Orleans in 1986. Dr. Foundas completed her Neurology residency training at the University of Florida in Gainesville where she also trained with Dr. Kenneth M. Heilman as a Post-doctoral Research Fellow in Cognitive and Behavioral Neurology. Dr. Foundas came to New Orleans in 1992 as Assistant Professor of Neurology at Tulane University School of Medicine. She rapidly rose through the ranks to Professor of Neurology in 2003. Dr. Foundas served as the Director of Neurology Residency Training and Co-Director of the combined programs of Medicine-Neurology and Psychiatry-Neurology Residency Training from 1995 to 2008. Dr. Foundas was the Director of Medical Student Education in Neurology in 2007 to 2008.

Aging, Dementia, and Stroke

Hans von Holst received his Medical Doctor´s degree in 1976 at Karolinska Institutet and completed his specialist training in Neurosurgery 1982 at Karolinska University Hospital. In 1985 he earned his PhD when he also became Associate Professor in Neurosurgery, Clinical Neuroscience at Karolinska Institutet. Since 1988 he holds a position as Senior Physician in Neurosurgery at Karolinska University Hospital. During 1991-1996 he was appointed as Chairman of the Dept of Neurosurgery and Division Manager of the Neuroclinics at Karolinska University Hospital, respectively. From 1992 to 2006 he was appointed as chairman of the World Health Organization collaborating center for neurotrauma at Karolinska Institutet. Since 2003 he is Professor in Neuroengineering and Head of the Division of Neuroengineering at the Royal Institute of Technology in Stockholm. He has over 120 original research publications, book chapters and books.

Dementia,Vascular Dementia,Neurosurgery

Experienced manager with a demonstrated history of working in care homes for the elderly who suffer Alzheimer’s disease and dementia. A specialist in the field of Alzheimer care with relentless curiosity, intellectual and creative personality. Strong professional with a Master's degree in Psychology from SWPS University of Social Sciences and Humanities, BA (Hons) degree in Tourism Management from Bournemouth University and course in Psychology of Addiction from Oxford University. Member of British Psychological Society BPS.

Alzheimer care

Soraya L Valles graduated in Biological Science at the University of Valencia in 1985 and in 1996 she finished her PhD in the IIC Institute looking for astrogliogenesis during brain development. In 1997 she spent three years at Hallamshire Hospital, Sheffield, UK. She was working in inflammation and regulation of IL-1 and IL-1 receptor. In 2000 she returned to Spain at Department of Physiology, Faculty of Medicine in University of Valencia until now. She is working in toxicity in developmental and neurodegenerative disease (such as Alzheimer’s disease) looking for oxidative stress and inflammation mechanisms.

Neurodegenerative disease, Inflammation mechanisms, Alzheimer’s disease

Mourad Tayebi is Associate Professor in Biomedical Sciences at the School of Medicine, Western Sydney University, AUSTRALIA. Dr. Tayebi is an international expert in the field of PROTEIN MISFOLDING DISEASES, with specific focus on investigating the molecular mechanisms underlying pathogenic protein misfolding and characterizing the misfoldome associated with these disorders. Dr. Tayebi’s team is very active in the development of early blood diagnostic test screen for Alzheimer and effective therapies for neurodegenerative diseases.

Protein misfolding diseases, Blood Diagnostic Test, Neurodegenerative Diseases

TY Chang shares the same laboratory with his wife and long-term collaborator Dr. Catherine Chang at Geisel School of Medicine at Dartmouth. They have been working on cholesterol metabolism research for more than four decades. The Changs and their colleagues did ground breaking work by identifying the gene that encodes the cholesterol storage enzyme acyl-CoA:cholesterol acyltransferase 1 (ACAT1/SOAT1). For this work, Dr. T.Y. Chang received a MERIT award from NIH, USA. More recently, the Chang lab at Dartmouth demonstrated ACAT1 as a potential target for treating several human diseases, including Alzheimer’s disease and Niemann-Pick type C disease.

Niemann-Pick type C disease, Alzheimer’s disease, cholesterol homeostasis.

Catherine Chang is the co-Principal Investigator of the Chang laboratory at Geisel School of Medicine at Dartmouth, with her husband and long-term collaborator Dr. T.Y. Chang as the PI. They have been working on cholesterol metabolism research for more than four decades. The Changs and their colleagues did ground breaking work by identifying the gene that encodes the cholesterol storage enzyme acyl-CoA:cholesterol acyltransferase 1 (ACAT1/SOAT1). Subsequently, they performed extensive functional analysis of the enzyme. More recently, they demonstrated ACAT1 as a potential target for treating several human diseases, including Alzheimer’s disease and Niemann-Pick type C disease.

Alzheimer’s disease and Niemann-Pick type C disease, cholesterol storage enzyme.

Jerzy Leszek is a full time professor of psychiatry at the Medical University in Wroclaw , Poland ,vice –director of the Psychiatry Department and head of Alzheimer’s Disease Lab. He is author and co-author more than 210 papers (especially from old age psychiatry), some chapters to the books published in reputed Polish and international journals and serving as an editorial board member of several journals .He is Scientific Editor and co-author of first Polish academic handbook on Alzheimer’s disease and seven another academic handbooks from psychogeriatry , member a lot of scientific associations eg founder and president of Lower Silesian Association of Alzheimer’s Families, first of its kind in Poland and Former Member of Board of Directions of International Psychogeriatric Association and President of Polish Psychogeriatric Association.

Alzheimer’s disease Therapy of dementia disorders in the light of new technologies :nanotechnology, proteomics, metabolomics, genomic medicine, personalized therapy Molecular base of neurodegenerative disorders Rehabilitation and physical activity of dementia disorders

updating soon...........

updating soon...........

Michael Entzeroth is currently Chief Scientific Officer/Chief Operating Officer of Cennerv Pharma (S) Pte Ltd in Singapore, a company focused on the development of novel drugs for the treatment of central nervous diseases. From 2007 to 2013, he was the Deputy Director and Vice President Research and Development and Deputy Director of the Experimental Therapeutic Centre, Biopolis, Singapore. Previously, he was Chief Scientific Officer of S*BIO Pte Ltd in Singapore and between 1999 and 2002, as Vice President of CEREP SA in France, he was a member of the Executive Management Committee. From 1985 to 1999, with Boehringer Ingelheim, Germany, he was responsible for a variety of drug discovery programs. A number of drug candidates, he worked on during his career, are either on the market or in advanced clinical stage. Over the years, results from his work have been published in more than 50 publications in peer-reviewed scientific journals.

.

Dr. Goldsmith has been a professor of surgery for more than forty years and a student of medical history throughout his life. He wrote the book A Conspiracy of Silence: Franklin D. Roosevelt—Impact on History. He also invented several surgical procedures including an operation to control Alzheimer’s disease, a procedure to treat acute and chronic spinal cord injuries, as well as an operation to eliminate the need for a permanent colostomy. He is an author of 265 papers or book chapters, has edited four surgical texts, and has received honorary degrees from two Chinese universities. He is a surgeon, worldwide lecturer, and adviser on the application of his surgical procedures

Alzheimer’s disease

Thomas E Nordahl M.D, PH.D is a professor emeritus at UV Davis school of Medicine. He did Psychiatry Residency from University of California, Davis. He worked as Junior staff at National Institute of Mental Health, Senior Clinical Fellow (NRSA), National Inst. Mental Health 1988-1989 Senior Staff Fellow, National Inst. Mental Health 1989-1995 Assistant Professor of Psychiatry, U.C. Davis Medical Center 1989-1991 Guest Scientist, Lawrence Berkeley Laboratory 1991-2003 Staff Scientist, Lawrence Berkeley National Laboratory 1991-1994 Staff Physician, (PET consultant) Palo Alto VAMC 1995-1999 Research Director, Napa State Hospital 2000-2001 Sabbatical at SRI -Department of Behavioral Neuroscience and Lucas MRS Center, Stanford University 1996-2002 Associate Professor, Psychiatry & Behavioral Sci, U.C. Davis Medical Center His Awards and Professional Societies include in 1965 Central Valley (California) Mathematics Quiz Finalist, 1966 California State Scholarship Finalist, 1971 NSF Student Trainee Grant, 1979 Summer Fellowship at Medical University of South Carolina,1986-1988 National Research Service Award, 1972- Member of American Mathematical Society, 1985- Member of American Association for the Advancement of Science, 1992 Member West Coast College for Biological Psychiatry, 1993- Member of Society for Nuclear Medicine, 1994- Fellow Canadian College of Neuropsychopharmacology, 1995- Member of Society for Biological Psychiatry,2013 – December Elected Member College: ACNP His service include 1973-1974 Graduate Curriculum Committee, U.C. Davis, Student Representative, 1975-1976 Member Computing Services Comm., Cal. State College, Stanislaus, 1979-1980 Student Government Rep., Medical Univ. of South Carolina,1984-1985 President Psychiatry Residents Association, U.C. Davis, 1986-1988 NIMH "PET" Representative to Nuclear Medicine,1990-1992 Assistant Training Director, U.C. Davis –Psychiatry, 1992-1994 Psychiatry Course Director Sophomore Medical Class, 1994-1994 Member School of Medicine Research Priority Committee, 1995-2000 Director of Neuroscience/Psychopharmacology course for interns, 1996-2000 Human Subjects Review Committee, 2005-2010 Human Subjects Review Committee,2009-2011 Soc. Biological Psychiatry Planning Committee for,2013 Apr Training Human Subjects Review Committee

Neuroscience

Dr. Pappolla's training included 3 complete medical residencies and 2 fellowships (Neurology, Clinical Pathology, Anatomic Pathology, Neuropathology, Pain Medicine), a PhD in human aging with a postdoc/sabbatical in molecular biology and over 20 years of academic practice. He holds active board certifications in these 5 areas (Neurology, Clinical Pathology, Anatomic Pathology, Neurology, Pain Medicine). Some of his research work is cited in several thousand textbooks worldwide, with many papers reaching from 300 to over 1000 citations in peer reviewed journals. His lab was among the first to identify evidence of oxidative stress in Alzheimer's disease brain. In collaborations with Dr. Larry Refolo, Dr Suzana Petanceska at the NIH, Dr. Daniel Zambon in Spain and others, we conducted groundbreaking research on hypercholesterolemia as an early risk factor for Alzheimer's disease. As a neuropathologist, he described several unique neuropathologic lesions including the colloid body of Parkinson's disease (later renamed "pale body") and the ubiquitinilated "dot like inclusions" in aged brains. One other important contribution was the development of neuroprotective drugs as potential therapeutic agents. He identified of several naturally occurring neuroprotective substances like indole-3-propionic acid and others. Dr. Pappolla served as a consultant for the National Institutes of Health in the United States including being a chartered member of numerous study sections for over 25 years and as a full professor or faculty at several medical schools (LSU New Orleans, Mount Sinai Medical School in New York City, University of Texas) where he taught Neurosciences to medical students and medical residents for over 20 years. Currently, he holds a hybrid academic-private practice position in the Houston area. Dr. Pappolla can be contacted at www.SMPSClinic.com

Neuropathology

He completed MBBCH very good with honors on Nov 1982 and completed Master of General Surgery in 1987.He did fellowship in the department of Neurosurgery in 1994.He did doctorate degree in Neurological surgery in 1994.and member congress of American Neurological Surgeons on 2000 He is the House officerin Ministry of Health Hospitals and Alexandria university Hospitals for one year from 1983 to 1984.He worked as physician in the Ministry of Health Hospitals from 1984 to 1987.He is Registrar of Neurosurgery in private hospital from 1987 to 1988.He is Assistant lecturer of Neurosurgical department of Alexandria University Hospitals from 1988 to 1994.He is chief consultant of Neurosurgery in Saqr Hospitals, UAE from 2000 to 2003.He visit to Neurological surgery department, Royal College of Medicine,London in 2001. He is working as Professor of Neurosurgery department at Alexandria University from 2010 to till date.

Neurology and Neurosurgery

Academic background: 1956-1960 The Hebrew University, Jerusalem M.Sc. Physiology, 1960-1966 The Hebrew University, Jerusalem Ph.D. Neurophysiology 1966-1968 Johns-Hopkins Univ., Baltimore Post Doc. Biomedical Engineering Previous employment: 1981- 2003 The Hebrew University, Jerusalem. Professor Neurophysiology 2003- 2014 Bar-Ilan University, Ramat-Gan Professor Neurophysiology 1973 - 1981 The Hebrew University, Jerusalem Assoc. Prof. Neurophysiology 1969 - 1973 The Hebrew University, Jerusalem. Senior Lect. Neurophysiology 1968 - 1969 The Hebrew University, Jerusalem Lecturer 1966 - 1968 Johns Hopkins Univ., Baltimore Post doc. Biomed. Eng. Administrative appointments: 2003 - 2012 Director, Gonda Multidisciplinary Brain Research Center, Bar-Ilan University 2003 – 2004 Add-hoc committee on Computational Neuroscience, BMBF, Germany 1996 – 1999 Director, Life-Sciences division of the Israel National Science Foundation. 1992 - 1999 Director, The Interdisciplinary Center for Neural Computation. 1984 - 1994 Director, The Israel Center for Psychobiology. 1977 - 1980 Director, The Israel Center for Psychobiology. 1974 - 1977 Chairman, Department of Physiology. Honors: 1968 Back prize for 3 papers on excitability of EEG synchronizing and desynchronizing neurons. 1971 I.A.P.I. First prize for work on "Computer aided analysis of nerve cell activity". 1980 Dr. Mona and Dr. Ernest Spiegel Chair of Neurophysiology 1980 Visiting professor, Universite de Lausanne 1986 Visiting professor, University of Pennsylvania 1986 Johns Hopkins Society of scholars 1996 Teva founders prize for outstanding work in brain research 1997 Miller visiting professor, UC Berkeley, USA 2004 Emet (Prime Minister of Israel prize), Israel 2012 Valentino Braitenberg's Golden Neuron award

Neurophysiology

Education: He did his M.D Neurosurgery from Alexandria University from 1980-1986 He did his M.sc General surgery from Alexandra University from 1977 to 1980 Experience: He worked as General secretary at Annual Conference of the Department of Neurosurgery,Alexandria University at Egypt in 2009. He worked as General secretary at Annual Meeting of the Spine Conference of the Department of Neurosurgery at Alexandria University, Egypt in 2008 and 2009. He is presently Board Member of Egyptian Society of Neurosurgery, Egypt. He is a Member of American Congress of Neurosurgery from 1991. He attended Conferences such as Egyptian Society of Neurosugery Annual Conference etc. Awards and Honors: He received Scientific Activity Award of the Egyptian Society of Neurosurgery,2007. Hi received Scientific Excellence Award of Assult University, 2005. He received Appreciation Award of the Egyptian Society of Neurosurgery,2000

Neurosurgery

Elena Paley has a PhD degree in molecular biology. Dr. Paley is a solo inventor of the metabolic model of neurodegeneration induced by biogenic amine tryptamine. The projects of Dr. Paley focus on alterations of protein biosynthesis machinery in neurodegeneration and human gut microbial-host interactions in Alzheimer’s disease. Dr. Paley is a founder and co-founder of Expert Biomed, Inc. and Stop Alzheimers Corp. The projects are conducted in collaboration with Harvard University, Brandeis University, University of Miami, University of Texas at San Antonio and more.

Alzheimers disease and Neurodegeneration

Dr.Sandeep Singh is a Neurobiologist with a strong background in Biochemistry and Biomedicine. He has dedicated more than 7 years to Neuroscience Research and used animal models system to investigate the therapeutic potential for Alzheimer’s disease using synthetic as well as natural compounds in Drosophila model system. After obtaining his M.Sc. degree in Biotechnology, he completed his Ph.D. from Department of Biochemistry, Institute of Science, Banaras Hindu University then moved to the Department of Neurobiology, The University of Chicago, IL, USA and worked on the role of microbial immune responses in AD pathogenesis. Currently, he is the Founder President of a non-profit organization in India named Indian Science Education and Technology Foundation (ISET Foundation) and working in the field of Science and Technology Promotion (Neurobiology and Biotechnology Research Promotion). The last 7 years research work come up with a couple of nice publications to his credit in journals of international repute like (International Journal of Alzheimer’s Disease, Neurotoxicity Research, Oxidative Medicine and Cellular Longevity, BBRC, Neurochemical Research, Neuroscience Letter, Current Drug Metabolism etc.) and 2 book chapter as mentioned in his CV. He is Member of the editorial board of several International neuroscience related journals. Also a member of several scientific societies like INDIAN ACADEMY OF NEUROSCIENCES, ALZHEIMER’S AND RELATED DISORDERS SOCIETY OF INDIA, American Academy of Neurology, International Society of Neurochemistry, Member of American Society of Neurochemistry.

Alzheimer’s Disease, Neurotoxicity Research, Oxidative Medicine and Cellular Longevity, BBRC, Neurochemical Research

Dr.Sandeep Singh is a Neurobiologist with a strong background in Biochemistry and Biomedicine. He has dedicated more than 7 years to Neuroscience Research and used animal models system to investigate the therapeutic potential for Alzheimer’s disease using synthetic as well as natural compounds in Drosophila model system. After obtaining his M.Sc. degree in Biotechnology, he completed his Ph.D. from Department of Biochemistry, Institute of Science, Banaras Hindu University then moved to the Department of Neurobiology, The University of Chicago, IL, USA and worked on the role of microbial immune responses in AD pathogenesis. Currently, he is the Founder President of a non-profit organization in India named Indian Science Education and Technology Foundation (ISET Foundation) and working in the field of Science and Technology Promotion (Neurobiology and Biotechnology Research Promotion). The last 7 years research work come up with a couple of nice publications to his credit in journals of international repute like (International Journal of Alzheimer’s Disease, Neurotoxicity Research, Oxidative Medicine and Cellular Longevity, BBRC, Neurochemical Research, Neuroscience Letter, Current Drug Metabolism etc.) and 2 book chapter as mentioned in his CV. He is Member of the editorial board of several International neuroscience related journals. Also a member of several scientific societies like INDIAN ACADEMY OF NEUROSCIENCES, ALZHEIMER’S AND RELATED DISORDERS SOCIETY OF INDIA, American Academy of Neurology, International Society of Neurochemistry, Member of American Society of Neurochemistry.

Alzheimer’s Disease, Neurotoxicity Research, Oxidative Medicine and Cellular Longevity, BBRC, Neurochemical Research

Ricardo B. Maccioni M.D., Ph.D. is a Professor of Neurology at the Medical School, and Professor of Neurosciences, University of Chile. He also serves as the Director of the Laboratory of Molecular Neurosciences, Scientific Director of the International Center for Biomedicine (ICC) and Senior Investigator of the Brain/Mind Program in Chile. He has served as Associate Professor at the University of Colorado Medical School, Denver, U.S.A. He received his doctoral degree in 1975, and was a postdoctoral fellow at the National Institutes of Health, the University of Colorado Health Sciences Center and a visiting scholar at and the Max Plank Institute for Biophysics in Germany. He is a world class scientist that has made some of the world leading contributions to the cell biology of neuronal cells and the study of Alzheimer’s disease. His discoveries on the role of tau protein in the pathogenesis of this disease, his neuroimmunomodulation theory of neurodegenerative disorders, the design of a new in vivo neuroimaging technology, novel biomarkers for its early diagnosis and innovative approaches for the treatment of this disease, are among his major contributions. On the basis of these and numerous other findings, he is considered among the leading investigators in Alzheimer´s disease. Dr. Maccioni was ranked among the three Chilean scientists with the highest impact factor in a recent study on science productivity. He has served as Associated Editor of the Journal of Alzheimer´s Disease, and the board of J. Alzheimer´s Reports, Journal of Neurochemistry, Therapeutic Advances in Chronic Diseases, Frontiers in Dementia and Archives of Medical Research. He is co-author with George Perry of the recent book “Current Hypotheses and Research Milestones in Alzheimer´s Disease”, among other 10 books in this medical field. Maccioni has made outstanding achievements in the training of 59 young scientist, and is the author of 146 publications in high-impact journals and 18 patents. His scientific findings are characterized by the innovative approaches to elucidate complex problems of modern medical research. He has received more than sixty research grants and several international prizes, including awards from the Alzheimer´s Association, the Milheim Foundation, Presidential Chair in Science, Chacellor´s medal of the University of Chile, and Doctor Honris causa at several universities. His leadership is further attested by being the founder of IMBO (Ibero-American Molecular Biology Organization), the Millennium Institute CBB, and the International Center for Biomedicine, a world class center of excellence. He has organized over forty international conferences with prominent neuroscientists from all over the world.He is a also member of the Innovation Circle of ICARE in Chile, the National Academy of Sciences, Scientific Director of Neuroinnovation and advisor for several important scientific institutions. He is also an elected member of the Danna Alliance for Brain Inititives.

In the field of technological innovation he has made contributions in monitoring new molecules for the treatment of Alzheimer´s disease.

Federico Ortiz-Moreno received a Bachelor's degree in psychology from the University of Monterrey, with emphasis in the Social Area He is Journalist and Columnist of some newspapers in Monterrey, Mexico, as well as a contributor of various magazines and newsletters, both national and international.He has received two Literature and Arts Diploma Awards. He has been a contributor to BBC London.He has been author of several books of short stories and poems, translated into four languages.He has been a founding member and first President of the Alzheimer's Association of Monterrey.He has been former President of the Mexican Federation of Alzheimer's disease.In 2010, Member of the Governance Committee of the Alzheimer's Disease International (ADI) based in London.He has participated as a speaker in more than 20 countries, and has contributed to the formation of several support groups and associations, both national and international level.Director and coordinator of the newsletter called “Alzheimer para todos”.He has been author of more than 250 articles of topics cultural and more than 100 about Alzheimer's with translations into various languages. He has received the National Award for volunteer Mexican 2007 by SEDESOL (Minister of Social Development in Mexico)Special Award “45 stories of success” by the Universidad de Monterrey, in 2014.Member of National Geographic Society He has been benefactor members of the Real Academia Española.

Alzhiemers disease

Dr.Howard Federoff has joined University of California, Irvine as Vice-Chancellor for Health Affairs and Dean of the Shool of Medicine.Federoff comes to UC Irvine from Georgetown University,where he served as Excecutive Vice president for Health services and Excecutive dean of the school of Medicine.Dr. Federoff received his MS, phD and MD degrees from the Albert Einstein college of Medicine,and did his Internship, Residency and Fellowships at Massachusetts General Hospital/Harvard Medical School.

Dr.Federoff's research intrests include Gene theraphy and neurodegenerative diseases such as Prakinson's, Alzhiemer's and Prion diseases; he holds number of medical patents with number of other patents pending.His Research has received support from the National Science Foundation,National Institutes of Health, and the U.S department of Defence.He is widely published and has served as a reviewer for many Journals including Brain and Mind,Experimental neurology and Gene theraphy.

Aage R. Møller, PhD (D. Med. Sci.) is Professor of Cognition and Neuroscience and Endowed Chair in the School of Behavioral and Brain Sciences at the University of Texas at Dallas. He is the Chairman of the Institutional Review Board at the University of Texas at Dallas as well as the Chairman of the Board for the Tinnitus Research Initiative Foundation. He has done extensive research on tinnitus and has had a significant role in the development of neurophysiological monitoring.Dr. Aage Møller is known internationally for his innovative research on sensory systems and neural plasticity and for developing methods for reducing the risk of neurological deficits in neurosurgical operations.When Dr. Møller joined UT Dallas 1997, he became interested in abnormalities in the nervous system function among individuals with autism. He developed teaching programs in the biology of pain; sensory systems, neuroplasticity and he established the first university program in teaching IONM in a graduate program. During his time at UT Dallas, he was named the university’s “President’s Teaching Excellence Award,” won Teacher of the Year for the School of Behavioral and Brain Sciences, and was named distinguished lecturer in Cognition and Neuroscience. Dr. Møller earned his PhD in medical science at the Karolinska Institute in Stockholm, Sweden.My most recent book is "Neuroplasticity and its Dark Sides: Disorders of the Nervous System". I have been editor or co-editor of seven published books, most recently, "Textbook of Tinnitus", published by Springer 2010, 95 chapters and 785 pages. One of my books have been translated to Japanese and two have been translated to Chinese. I am the author or co-author of more than 200 articles in refereed journals, more than 100 book chapters. I was Editor-in-Chief (and founder) of the international journal, Hearing Research for 27 years (1978-2005); I am member of the Editorial Board of many other international journals. I am interested in teaching and I have developed new courses and have been writing books that are used in teaching. At The University of Texas I have developed courses such as "Biology of Pain", "Sensory Systems", "Neural Plastic and Disorders of the Nervous System", "Functional Human Neuroanatomy" and Intraoperative Neurophysiological Monitoring" that I teach in the Neuroscience Program of the School of Behavioral and Brain Sciences.

Aage R. Moller research intrests include function of middle ear and the cochlea, then the neuroscience of the auditory system, somatosensory and visual systems and of hyperactive motor disorders. He have used systems identification methods such as Winer kernel analysis of recordings from single nerve cells in the cochlear nucleus using pseudorandom noise stimuli. He is particularly interested in the role of neuroplasticity in disorders such as severe tinnitus, chronic neuropathic pain and spasticity and muscle spasm. He have also studied the role of the non-classical auditory pathways and their involvement in disorders such as tinnitus.

UC Irvine neurologist Arnold Starr, MD, PhD, a longtime chair of the Department of Neurology, has been selected as an honorary member of the American Academy of Neurology.Starr was the second neurologist to join the UC Irvine faculty and became the first chair of the Department of Neurology. He led the division of neurology, as it became a new department in 1977. He remained chair for 10 years. Although retired, Starr continues to teach and conduct research.“Dr. Starr is a wonderful example of the best that neurologists can achieve in their lifetimes,” said Steven L. Small, PhD, MD, Stanley van den Noort Professor and current chair of the department. “In retirement, Dr. Starr continues to be active in teaching and research.” The AAN bestows honorary membership upon those individuals deemed by the Academy’s board of directors to have performed exceptional meritorious contributions to the field of neurology, with national or international impact.

Arnold Starr research intrests include Neurological disorders affecting cognition, sensation and motor behaviors. He is investigating the neurobiological bases of clinical disorders of the nervous system that affect sensation, motor performance, and cognition. His studies employ electrophysiological and behavioral methods to define functional mechanisms underlying clinical syndromes relevant for specific research question. The current interests are two fold:1) Hearing disorder called Auditory Neuropathy and 2) Memory changes in Aging and Dementia

Dr. Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration.

The major focus of this laboratory has been to study the mechanisms of topographic regulation of neuronal cytoskeletal proteins regulation by phosphorylation and neurodegeneration. In a normal physiological state, cytoskeletal proteins are phosphorylated extensively in the axonal compartment of a mature neuron. Although all the substrates, kinases, phosphatases and their regulators are synthesized in neuronal cell bodies, little or no cytoskeletal protein phosphorylation has been detected in the cell body compartment. Under a variety of neuropathological conditions, however, such as ALS, Alzheimers Disease, or Picks disease, hyperphosphorylation of these molecules has been found in abnormal aggregates within cell bodies, usually correlated with massive neuronal cell death. The mechanisms underlying these profound compartmental shifts in neuronal phosphorylation are not well understood.The normal physiological processes within neurons are controlled by signal transduction mechanisms that regulate the balance between protein kinase and protein phosphatase activities. We have shown that the most abundant and extensively phosphorylated motifs in the c-terminal domains (lys-ser-pro-, or KSP) are primarily phosphorylated by proline directed kinases, cdk5 and MAP kinases. Moreover, we have demonstrated that this phosphorylation is due to activation of the signal transduction cascade. Recently, we have focussed on the other part of this regulation, the protein phosphatases. The other project is to study the expression, regulation and role of neuronal Cdk5 in nerve cell function.Cdk5 is a unique multifunctional kinase. Unlike other cyclin-dependent kinases, it is expressed predominantly in post-mitotic neurons, its activity modulated by association with nervous system-specific propeins. Since its identification and characterization in our laboratory, we have been intensively studying its mechanisms of regulation and its role in nerve cell function.

Stephen D. Skaper received a PhD in biochemistry from the University of South Dakota and Laurea in chemistry from the University of Padua, Italy. He is currently Adjunct Professor in the Department of Pharmaceutical and Pharmacological Sciences (section on Pharmacology and Anesthesiology) at the University of Padua. From 1998-2008 he was a Senior Group Leader for Neurodegeneration Research, Neurology & GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, United Kingdom. Prior to that he held academic research positions in the Department of Biology at the University of California, San Diego. Dr. Skaper has authored/co-authored over 300 research papers, book chapters and monographs, as well as having guest-edited six journal thematic issues and a volume of Methods in Molecular Biology on neurotrophic factors. He is Editor-in-Chief of CNS & Neurological Disorders Drug Targets, the Associate Editor of the American Journal of Neuroprotection and Neuroregeneration, and a Councillor of the International Association of Neurorestoratology. His research interests focus on the role of immune cells and their interactions in neuroinflammation, in particular with regards to neuropathic pain and autoimmune demyelinating diseases like multiple sclerosis, and the development of therapeutic strategies based on natural molecules. He is a member of Sigma I, Phi Lambda Upsilon, Alpha Chi Sigma, the Society for Neuroscience and the International Society of Cerebral Blood Flow and Metabolism.

Molecular biology and cellular mechanisms of cell death in CNS aging, neurodegenerative disorders and neuroinflammation, astrocyte-microglia interactions, pharmacological modulation of oligodendrocyte precursor maturation and demyelinating diseases. Track record of drug discovery project leadership in kinases, ion channels, G-protein-coupled receptors, DNA repair enzymes, growth factors, identification and optimization of tools for target validation studies, utilising RNAi, conditional and viral knockdown\outs\ins, transcriptomics, proteomics and in vitro cell-based disease or mechanism relevant assays in rodent systems.

Hsien-Yuan Lane is distinguished Professor and Director of Graduate Institute of Biomedical Sciences, College of Medicine. He is the Director, Department of Psychiatry, College of Medicine. HY Lane received Ph.D. from National Defense Medical Center (Taiwan) in 2000 and he received M.D from Taipei Medical University (Taiwan) in 1987. HY Lane Academic distinctions include Y.Z. Hsu Scientific Paper Award, Biotechnology Category, Taiwan in 2006, The 10th National Innovation Award, Taiwan in 2013, The 24th Wang-Ming-Ning Award, Taiwan in 2014 Ministry of Science and Technology Outstanding Research Award, Taiwan in 2014 CNS Drug Innovation Award and The International of College of Neuropsychopharmacology 2016

Hsien-Yuan Lane is distinguished Professor and Director of Graduate Institute of Biomedical Sciences, College of Medicine. He is the Director, Department of Psychiatry, College of Medicine. HY Lane received Ph.D. from National Defense Medical Center (Taiwan) in 2000 and he received M.D from Taipei Medical University (Taiwan) in 1987. HY Lane Academic distinctions include Y.Z. Hsu Scientific Paper Award, Biotechnology Category, Taiwan in 2006, The 10th National Innovation Award, Taiwan in 2013, The 24th Wang-Ming-Ning Award, Taiwan in 2014 Ministry of Science and Technology Outstanding Research Award, Taiwan in 2014 CNS Drug Innovation Award and The International of College of Neuropsychopharmacology 2016

Academic graduation - Doctor of medicine graduated from Monastir Medicine Faculty Jul 2002 - Specialist of Neurology Sept 2002 - Assistant Professor of Neurology at the Department of Neurology University Hospital of Monastir and the Medicine Faculty of Monastir 2003 - Associate Professor of Neurology at the Department of Neurology University Hospital of Monastir and the Medicine Faculty of Monastir 2010 - Specialized master of epileptology graduated from Sfax University Nov 2008 Clinical competence - Hospital practitioner specialized in general neurology: competence in the care of the neurological diseases with particular competence in the care of the neuro-degenerative and neuromuscular diseases - Competence in clinical electrophysiology: practice of EMG and EEG since 2000 - Competence in the treatment with toxine botulinique patients affected by cervical dystonia: facial hemispasm and of blepharospasms since 2010 Others competences * Teaching Experience • Teaching neurology at Monastir Medicine Faculty since 2003 • Teaching neurology at Monastir Pharmacy Faculty since 2005 • Teaching neurology at Monastir College of Health’ Technicians since 2010 • Teaching neurology at Monastir High School of Nurses since 2010 *Clinical Trials Experience : participation to 7 phase III international multi centric studies *Directions of 14 doctoral theses and memoirs of the end of studies

Neurology

He joined the neuropsychiatry residency at Ain shams university Cairo, Egypt from 2001 till 2003, finished his MD in neurology and got his doctorate by 2008. He have been assigned as lecturer of neurology and his main concern was in the field of NEUROVASCULAR INTERVENTIONAL RADIOLOGY. He finished his fellowship in interventional neurology at ZURICH University, Switzerland as F.I.N.R. by 2013. Now he is an Assistant clinical professor of neurology, GMU University and GMC hospital, Ajman, united Arab of emirates (UAE) SINCE 2010. He have publications in many journals as OPEN JOURNAL OF MEDICAL IMAGING (OJMI), The Egyptian Journal of Radiology and Nuclear Medicine, the European Journal of Neurology, Neurology of India. He is an editor in chief at NEUROLOGICAL SCIENCE JOURNAL

Stroke, Epilepsy Managment

Clinical & basic science trained neurologist with neuromuscular/rare/orphan disease fellowships and therapeutics development expertise in Neurology, Cardiology and Rare Disease applications.

Neuromuscular

He is the Vice Chair of Neurology Department. He is associate professor of Neurology & Radiology Department at Texas Tech University Health Science Center. With him comes around 15 years of experience in the field of Neurology.

Neurology & Radiology

Jerzy Leszek is a full time professor of psychiatry at the Medical University in Wroclaw , Poland ,vice –director of the Psychiatry Department and head of Alzheimer’s Disease Lab. He is author and co-author more than 210 papers (especially from old age psychiatry), some chapters to the books published in reputed Polish and international journals and serving as an editorial board member of several journals .He is Scientific Editor and co-author of first Polish academic handbook on Alzheimer’s disease and seven another academic handbooks from psychogeriatry , member a lot of scientific associations eg founder and president of Lower Silesian Association of Alzheimer’s Families, first of its kind in Poland and Former Member of Board of Directions of International Psychogeriatric Association and President of Polish Psychogeriatric Association.

Neurodegeneration processes/Alzheimer’s disease Therapy of dementia disorders in the light of new technologies :nanotechnology, proteomics, metabolomics, genomic medicine, personalized therapy Molecular base of neurodegenerative disorders Rehabilitation and physical activity of dementia disorders

Hsien-Yuan Lane is presently working as Professor and Chief in the Department of Psychiatry, China Medical University and Hospital, Taichung, Taiwan. He completed his Ph.D in 2000 from National Defense Medical College, Taipei. He received many honors. He is also an Editorial Board Member for many journals. He published many articles and many books. He acts as a invited Speaker for International Symposiums.

Schizophrenia, NMDA, Psychopharmacology, Social cognition, Neurocognition, Genomics, Neuropsychopharmacology,Pharmacogenomics,Psychiatric genetics, Cognitive neuroscience

Karyn Casey is a Speech-Language Pathologist in Johannesburg, South Africa. Her work combines running a multidisciplinary private practice, a teaching appointment at the University of the Witwatersrand, and delivering a range of training workshops for ICU staff, care facilities and fellow rehabilitation professionals. Karyn also works within a community- based brain injury rehabilitation program. She is a presenter at a number of workshops and keynote addresses at local and international conferences on the subject of swallowing disorders. She has also participated in a number of international conferences on neurological rehabilitation and dysphagia, including the annual European Society on Swallowing Disorders and the United Kingdom Swallowing Research Group Meeting held annually in London. Most recently, she presented at the World Congress for Neurological Rehabilitation held in Istanbul in 2014. Karyn is a member of the World Healthy Ageing Congress 2015 Scientific Committee, where she heads the Allied Health and Mutlidisciplinary Portfolio. She is also a leading researcher of the MYSTROKE initiative, which is the national coordinating body to develop and coordinate stroke guidelines for South Africa, on behalf of the South African Stroke Society. Her primary clinical interests are in the areas of adults with a range of neurogenic disorders of speech, language and swallowing. She has a specialist involvement in the rehabilitation of dysphagia, and research interests in the relationship between cognition and dysphagia in dementia, as well as Motor Neuron Disease (MND) and dementia. Karyn is the only advanced VitalStim® Speech-Language Pathologist practitioner in South Africa. Having completed her primary training in the USA in 2008 and her advanced training in 2010, she provides VitalStim® therapy to a number of patients within her private practice. Her fellow colleagues within her practice are also VitalStim® certified. The practice currently treats in excess of 200 patients using VitalStim® every quarter. Karyn serves as a mentor for a number of VitalStim® practitioners in South Africa. Karyn Casey represents the South African Speech-Language and Hearing Association as an advisor on their joint panel with South Africa's major private healthcare provider (Discovery Health). Karyn is also a reviewer for a number of scientific journals. She is currently the President of the South African Neurological Rehabilitation Association and is the President of the Local Organising Committee for the World Congress of Neurological Rehabilitation to be held in Cape Town in 2020.

Neurology

John Grandy has been a physician assistant in urgent care, psychiatry, and internal medicine for almost 10 years. Prior to this he completed a M.S. in neurophysiology and molecular immunology at Roswell Park Cancer Research Institute, in Buffalo, New York. He has published several peer reviewed medical articles and book chapters on many topics including Alzheimer disease and consciousness. He is the originator of the proposal of the very first neurogenetic model to account for human consciousness.

Alzheimer disease,Neurogenetics Consciousness studies, Genetic-linked neurodevelopmental disorders, Addiction and the neurogenetic pathways involving the ∆FosB transcription factor

Wutian Wu has received his medical degree in Sun YatSen University of Medical Sciences, Guangdong, China in 1975 and a Master Degree in Neuroanatomy in the same institute in 1981. He was a clinician and later a teacher for medical students for more 10 years in Mainland China and went to US for his oversea study and work. Prof. Wu received his PhD degree in Neuroscience in 1991 and continued to work in Eastern Virginia Medical School till 1996. Prof Wu joined the Department of Anatomy, Faculty of Medicine, The University of Hong Kong in Jan. 1996 as an assistant professor, promoted to associate professor in 1997 and professor in 2008. Prof Wu ’s research is well recognized. His contributions include: 1 A total of over 100 original peer review articles with more than 2000 citations received; 2 Initiation of 14 active international and local collaborative studies with a few of outstanding research groups Centers; 3 A total of 29 research grants 23 as principal investigator and 6 as coinvestigator with total of over HK 20 millions awarded; 4 More than 40 invited lectures, visiting professorship

1. Gene expression changes of motoneurons after axonal injury and their potential roles in neuronal degeneration and regeneration. 2. Experimental studies on surgical treatment of avulsed spinal nerve roots in brachial plexus injury. 3. Potential treatments for spinal cord injury. 4. Research in other areas: A) to explore the potential use of neural stem cells in replacing died neurons due to CNS injury or disorder. B) to investigate a possible application of nano-materials in neuronal injury. C) to investigate new drugs for the treatment of neural degenerative disease.

WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

Neurology,Psychiatry,Stroke

-

-

-

-

-

-

Dr. George Perry is currently the dean of the College of Sciences and professor of biology at the University of Texas at San Antonio. After graduation in Zoology from University of California, Santa Barbara, he headed to Scripps Institution of Oceanography and also studied at Hopkins Marine Station of Stanford University and the Marine Biological Laboratory of Woods Hole and obtained his PhD in Marine Biology in 1979. Dr. Perry joined the faculty of Case Western Reserve University in 1995, where he currently holds an adjunct appointment. He is a Fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, Royal Society of Medicine, Royal Society of Chemistry, Society of Biology and the Linnean Society and past-president of the American Association of Neuropathologists. He has been elected member of the Spanish Royal Academy of Sciences, Mexican Academy of Sciences and Academy of Sciences Lisbon; Iberoamerican Molecular Biology Organization, Dana Alliance for Brain Initiatives and won the Distinguished Professional Mentor Award from the Society for the Advancement of Chicanos and Native Americans in Science, Senior Investigator Award from the International College of Geriatric psychoneuropharmacology, Senior Fulbright Fellow and the National Honor Plaque of Panama for exceptional contributions to Neuroscience. Dr. Perry is on Board of the National Organization of Portuguese Americans and serves as Director of Education and Research.

-

-

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong. He joined the Chinese University of Hong Kong as an academic staff since 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.

-

-

Vahe Poghosyan received his MSc in Mathematics (1997) from Yerevan State University and PhD in Neurophysiology (2000) from National Academy of Sciences of Armenia. He held positions of Research Scientist in RIKEN Brain Science Institute in Japan (2000-2007), and Senior Scientist (2007-2016) and Director of Research Training Program (2011-2016) at AAI Scientific Cultural Services Ltd. in Cyprus. Currently, he is the Head of MEG Laboratory and Consultant Neuronavigation at King Fahad Medical City in Riyadh, KSA.